期刊文献+

Tespa1基因在慢性荨麻疹患者外周血单个核细胞中的表达水平及与病情相关性分析 被引量:2

Correlations between the Expression of Tespa1 and the Development of Chronic Urticaria
下载PDF
导出
摘要 目的探讨慢性荨麻疹患者外周血单个核细胞中Tespa1基因的表达水平及其与患者发病程度的相关性。方法慢性荨麻疹患者52例,健康人对照20例,用实时荧光定量PCR检测研究对象外周血单个核细胞(PBMCs)中Tespa1 mRNA的表达水平,分析Tespa1基因表达水平与慢性荨麻疹病情严重程度的相关性。结果慢性荨麻疹患者外周血中Tespa1基因的表达量明显低于正常人对照组,差异有统计学意义(P<0.01);同时Tespa1基因的表达与患者发病严重程度具有负相关性(P<0.001),而与外周血中Ig E抗体的水平并没有相关性(P>0.05)。结论 Tespa1分子可能在慢性荨麻疹的发生中发挥一定的作用。 Objective To investigate the correlations between the expression of Tespal and the development of chronic urticaria (CU). Methods Venous blood samples were collected from 52 patients with CU and 20 healthy human controls. Fluorescence-based real-time quantitative PCR was performed to determine the expression of Tespal in PBMCs from these subjects. Results The expression of Tespal in the patients were significantly lower than those in the healthy control ( P 〈 0.01 ) and negative correlation with the urticaria activity score (P 〈0. 001 ). However there was no significant correlation between the expression levels of Tespal and the serum levels of IgE (P 〉 0. 05). Conclusion The expressions of Tespal are reduced in PBMCs of patients with chronic urticaria, and negative correlated with the severity of urticaria.
出处 《中国皮肤性病学杂志》 CAS CSCD 北大核心 2015年第8期794-795,816,共3页 The Chinese Journal of Dermatovenereology
基金 浙江省自然科学基金(LY13H100002) 国家自然科学基金青年项目(31300733)
关键词 慢性荨麻疹 Tespa1 抗体IgE Chronic urticaria Tespal Antibody IgE
  • 相关文献

参考文献12

  • 1Staumont-Salle D, Dombrowiez D,Capron M ,et al. Eosinophils and urti- caria[ J]. Clin Rev Allergy hnmunol,2006,30( 1 ) : 13 - 18.
  • 2Kikuehi Y,Kaplan AP. Mechanisms of autoimmune activation of basophils in chronic urticaria [ J ]. J Allergy Clin lmmunol, 2001 , 107 ( 6 ) : 1056 - 1062.
  • 3Bingham CO. hnmunomodtflatory approaches to the management of chronic urticaria: an immune-mediated inflammatory disease[ J 1. Curt Allergy Asthma Rep,2008,8(4) : 278 -287.
  • 4Jain S. Pathogenesis of chronic urticaria: an overview [ J ]. Dermatol Res Pract ,2014,2014 : 674709.
  • 5Juhlin L, Johansson GO, Bennich H,et al. Immunoglobulin E in derma- roses. Levels in atopic dermatitis and urticaria [ J ]. Arch Dermatol, 1969,100(1): 12-16.
  • 6Krause K,Metz M, Makris M,et al. The role of intedeukin-I in aller'- related disorders[ J ]. Curr Opin Allergy Clin lmmuno102012,12 (5) : 477 - 484.
  • 7Hermes B,Prnchazka AK,Haas N,et al. Upregulation of TNF-alpha and I1.-3 expression in lesional and uninwlved skin in different types of urti- cariaEJ]. J Allergy Clin lmmunoi,1999,103(2 Pt 1): 307-314.
  • 8Ferrer M,Nakazawa K, Kaplan AP. Complement dependent'e of hista- mine release in chronic urticarial J]. J Allergy. Clin lmmunol, 1999, 104(I) : 169 -172.
  • 9Wang D,Zheng M, Lei L, et al. Tespal is involved in late thymoeyte de- velopment through the regulation of TCR-mediated signaling [ J ]. Nat Immunnl,2012,13(6) : 560-568.
  • 10Gascoigne NR,Fu G. Tespal : another gatekeeper for positive selection [J]. Nat lmmunol,2012,13(6): 530 -532.

二级参考文献6

  • 1Zuberbier T,Asero R,Bindslev-Jensen C,et al.EAACI/GA2LEN/EDF/WAO guideline:definition,classification and diagnosis of urticaria[J].Allergy,2009,64(10):1417-1426.
  • 2Zuberbier T,Asero R,Bindslev-Jensen C,et al.EAACI/GA2LEN/EDF/WAO guideline:management of urticaria[J].Allergy,2009,64(10):1427-1443.
  • 3Powell R J,Du Toit G L,Siddique N,et al.BSACI guidelines for the management of chronic urticaria and angioedema[J].Clin Exp Allergy,2007,37(5):631-650.
  • 4Zuberbier T,Bindslev-Jensen C,Canonica W,et al.EAACI/GA2LEN/EDF guideline:management of urticaria[J].Allergy,2006,61(3):321-331.
  • 5Zuberbier T,Bindslev-Jensen C,Canonica W,et al.EAACI/GA2LEN/EDF guideline:definition,classification and diagnosis of urticaria[J].Allergy,2006,61(3):316-320.
  • 6张宏誉.抗变态反应药临床试验方案要点[J].中华临床免疫和变态反应杂志,2009,3(3):161-166. 被引量:3

共引文献37

同被引文献3

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部